FULC Key Financial Ratios - Fulcrum Therapeutics, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	31.35	—	-26.24%	-27.36%
2026-03-31	34.33	—	-21.95%	-22.84%
2025-12-31	27.4	—	-20.44%	-21.46%
2025-09-30	17.7	—	-33.10%	-35.85%
2025-06-30	24.42	—	-31.99%	-34.15%
2025-03-31	28.71	—	-0.21%	-0.22%
2024-12-31	22.63	—	-3.73%	-4.00%
2024-09-30	18.44	—	-6.42%	-6.96%
2024-06-30	22.07	—	-6.88%	-7.39%
2024-03-31	20.38	—	-42.75%	-46.55%
2023-12-31	17.71	—	-37.77%	-41.39%
2023-09-30	18.65	—	-35.40%	-38.64%
2023-06-30	19.11	—	-32.78%	-35.74%
2023-03-31	21.02	—	-33.86%	-36.70%
2022-12-31	12.41	—	-48.47%	-55.23%
2022-09-30	15.49	—	-43.27%	-48.43%
2022-06-30	7.88	—	-53.37%	-64.82%
2022-03-31	10.94	—	-40.76%	-47.46%
2021-12-31	11.77	—	-34.40%	-38.22%
2021-09-30	11.95	—	-29.38%	-32.56%
2021-06-30	5.71	—	-53.18%	-66.13%
2021-03-31	6.49	—	-44.33%	-54.30%
2020-12-31	4.47	—	-54.65%	-74.40%
2020-09-30	4.99	—	-48.67%	-65.94%
2020-06-30	9.67	—	-46.11%	-54.70%
2020-03-31	5.95	—	-67.77%	-91.02%
2019-12-31	8.24	—	-74.86%	-94.86%
2019-09-30	12.26	—	-65.04%	-73.84%
2019-06-30	8.1	—	-104.09%	60.72%
2019-03-31	—	—	—	62.69%
2018-12-31	17.52	—	-37.99%	51.18%

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	27.4	—	-20.44%	-21.46%
2024-12-31	22.63	—	-3.73%	-4.00%
2023-12-31	17.71	—	-37.77%	-41.39%
2022-12-31	12.41	—	-48.47%	-55.23%
2021-12-31	11.77	—	-34.40%	-38.22%
2020-12-31	4.47	—	-54.65%	-74.40%
2019-12-31	8.24	—	-74.86%	-94.86%
2018-12-31	17.52	—	-37.99%	51.18%